Twenty-year trend of thyrotoxicosis and thyrotoxic periodic paralysis: a population-based cohort study.

IF 4.3 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM
European Thyroid Journal Pub Date : 2025-09-25 Print Date: 2025-10-01 DOI:10.1530/ETJ-25-0220
Gloria Hoi-Yee Li, Ching-Man Tang, Ray Shing-Hin Li, Grace Mengqin Ge, Annie Wai-Chee Kung, Kathryn Choon-Beng Tan, Elaine Yun-Ning Cheung, Ching-Lung Cheung
{"title":"Twenty-year trend of thyrotoxicosis and thyrotoxic periodic paralysis: a population-based cohort study.","authors":"Gloria Hoi-Yee Li, Ching-Man Tang, Ray Shing-Hin Li, Grace Mengqin Ge, Annie Wai-Chee Kung, Kathryn Choon-Beng Tan, Elaine Yun-Ning Cheung, Ching-Lung Cheung","doi":"10.1530/ETJ-25-0220","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Thyrotoxic periodic paralysis (TPP) is a rare but potentially lethal complication of thyrotoxicosis. Absence of large cohorts limits the conduct of epidemiology studies. We aimed to establish a population-based registry of thyrotoxicosis and TPP in Hong Kong and evaluate their trend.</p><p><strong>Methods: </strong>We developed algorithms to identify thyrotoxicosis and TPP cases from a representative electronic medical database in Hong Kong. Of the potential cases (thyrotoxicosis:83,184; TPP:999), we reviewed clinical notes and laboratory test records of 200 randomly selected cases. Population-based registries of thyrotoxicosis and TPP were subsequently established. Their standardized incidence rate, TPP-associated hospitalization rate, length of stay (LOS), and trends from 2002 to 2021 were evaluated.</p><p><strong>Results: </strong>Positive predictive values for thyrotoxicosis and TPP were 0.86-0.97, respectively, enabling establishment of population-based cohorts of incident thyrotoxicosis (n = 77,856) and TPP (n = 994). Age- and sex-standardized incidence rate (per 100,000 person-years) of thyrotoxicosis increased from 41.31 in 2002 to 69.51 in 2021 (average annual percentage change: 4.77%), with a similar trend observed in both sexes. TPP patients were predominantly male (93.66%). In 2002 and 2021, the age-standardized incidence rate (per 100,000 person-years) of TPP in males was 1.43 and 1.18, respectively, while that in females was 0.11 and 0.13, without a significant trend observed. TPP-associated hospitalization rate (90.91-100%) and median LOS (2-3 days) were steady across the two decades.</p><p><strong>Conclusion: </strong>This is the first study establishing a TPP cohort based on validated clinical data from an electronic medical database. It is important to keep monitoring the increasing incidence rate of thyrotoxicosis.</p>","PeriodicalId":12159,"journal":{"name":"European Thyroid Journal","volume":" ","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12478295/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Thyroid Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1530/ETJ-25-0220","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/1 0:00:00","PubModel":"Print","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Thyrotoxic periodic paralysis (TPP) is a rare but potentially lethal complication of thyrotoxicosis. Absence of large cohorts limits the conduct of epidemiology studies. We aimed to establish a population-based registry of thyrotoxicosis and TPP in Hong Kong and evaluate their trend.

Methods: We developed algorithms to identify thyrotoxicosis and TPP cases from a representative electronic medical database in Hong Kong. Of the potential cases (thyrotoxicosis:83,184; TPP:999), we reviewed clinical notes and laboratory test records of 200 randomly selected cases. Population-based registries of thyrotoxicosis and TPP were subsequently established. Their standardized incidence rate, TPP-associated hospitalization rate, length of stay (LOS), and trends from 2002 to 2021 were evaluated.

Results: Positive predictive values for thyrotoxicosis and TPP were 0.86-0.97, respectively, enabling establishment of population-based cohorts of incident thyrotoxicosis (n = 77,856) and TPP (n = 994). Age- and sex-standardized incidence rate (per 100,000 person-years) of thyrotoxicosis increased from 41.31 in 2002 to 69.51 in 2021 (average annual percentage change: 4.77%), with a similar trend observed in both sexes. TPP patients were predominantly male (93.66%). In 2002 and 2021, the age-standardized incidence rate (per 100,000 person-years) of TPP in males was 1.43 and 1.18, respectively, while that in females was 0.11 and 0.13, without a significant trend observed. TPP-associated hospitalization rate (90.91-100%) and median LOS (2-3 days) were steady across the two decades.

Conclusion: This is the first study establishing a TPP cohort based on validated clinical data from an electronic medical database. It is important to keep monitoring the increasing incidence rate of thyrotoxicosis.

甲状腺毒症和甲状腺毒性周期性麻痹的20年趋势:一项基于人群的队列研究。
目的:甲状腺毒性周期性麻痹(TPP)是一种罕见但具有潜在致命性的甲状腺毒症并发症。缺乏大型队列限制了流行病学研究的开展。我们的目的是在香港建立一个以人群为基础的甲状腺毒症和TPP登记,并评估其趋势。方法:我们开发了从香港有代表性的电子医疗数据库中识别甲状腺毒症和TPP病例的算法。在潜在病例中(甲状腺功能亢进:83,184例;TPP:999例),我们随机选择200例的临床记录和实验室检测记录进行复习。随后建立了以人群为基础的甲状腺毒症和TPP登记处。评估了他们的标准化发病率、与tpp相关的住院率、住院时间(LOS)及其2002 - 2021年的趋势。结果:甲状腺毒症和TPP的阳性预测值分别为0.86和0.97,从而建立了以人群为基础的甲状腺毒症(n=77,856)和TPP (n=994)队列。甲状腺毒症的年龄和性别标准化发病率(每10万人年)从2002年的41.31上升到2021年的69.51(平均年百分比变化:4.77%),两性的趋势相似。TPP患者以男性为主(93.66%)。2002年和2021年,男性TPP年龄标准化发病率(每10万人年)分别为1.43和1.18,女性为0.11和0.13,无明显趋势。与tpp相关的住院率(90.91%-100%)和中位LOS(2-3天)在二十年中保持稳定。结论:这是第一个基于电子医学数据库中验证的临床数据建立TPP队列的研究。持续监测甲状腺毒症的发病率是十分重要的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European Thyroid Journal
European Thyroid Journal Medicine-Endocrinology, Diabetes and Metabolism
CiteScore
6.70
自引率
2.10%
发文量
156
期刊介绍: The ''European Thyroid Journal'' publishes papers reporting original research in basic, translational and clinical thyroidology. Original contributions cover all aspects of the field, from molecular and cellular biology to immunology and biochemistry, from physiology to pathology, and from pediatric to adult thyroid diseases with a special focus on thyroid cancer. Readers also benefit from reviews by noted experts, which highlight especially active areas of current research. The journal will further publish formal guidelines in the field, produced and endorsed by the European Thyroid Association.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信